Residency · Orange, CA
Sponsored by University of California (Irvine)
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
The New England journal of medicine · 2023 · 703 citations · Dana Chase
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
The New England journal of medicine · 2021 · 855 citations · Krishnansu Tewari
From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment.
Cell · 2023 · 467 citations · Erica Wu
Survival with Cemiplimab in Recurrent Cervical Cancer.
The New England journal of medicine · 2022 · 385 citations · Krishnansu Tewari
Treatment advances across the cervical cancer spectrum.
Nature reviews. Clinical oncology · 2025 · 96 citations · Krishnansu Tewari
Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care.
Circulation · 2025 · 73 citations · Afshan Hameed
Cervical Cancer.
The New England journal of medicine · 2025 · 84 citations ·
How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals.
Nature medicine · 2021 · 310 citations · Erica Wu